Such T cells were also observed by Zhang et al.50 and Bassez et al.51 in other human breast cancer samples, and both studies demonstrated their reactivation with anti-PD-L1 therapy to harness their cytotoxicity against the tumor cells. This evidence concerns the gene CD274 and breast carcinoma.